NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

GUJARAT THEMIS BIOSYN LTD.

NSE : NABSE : 506879ISIN CODE : INE942C01045Industry : Pharmaceuticals & DrugsHouse : Private
BSE409.905.85 (+1.45 %)
PREV CLOSE ( ) 404.05
OPEN PRICE ( ) 408.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 35120
TODAY'S LOW / HIGH ( )404.05 414.60
52 WK LOW / HIGH ( ) 145.8435
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1981
Management Info
Dinesh S Patel - Chairman - Managing Director
Registered Office

Address 69 / C,G I D C Industrial Estate,Vapi,
Valsad Dist,
Gujarat-396195

Phone 0260-2430027 / 2400639

Email hrm@gtbl.in.net

Website www.gtbl.in

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
08Mar Gujarat Themis Biosyn informs about lo
Pursuant to Regulation 39(3) of the SEBI Listing Regulation, Gujarat The..
27Dec Gujarat Themis Biosyn informs about tr
Gujarat Themis Biosyn has informed that as per the Company's minimum Sta..
22Dec Gujarat Themis Biosyn informs about di
Gujarat Themis Biosyn has informed that it enclosed Disclosure under Reg..
10Nov Gujarat Themis Biosyn informs about tr
Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclo..
06Nov Gujarat Themis Biosyn informs about ne
In terms of Regulation 47 of the SEBI Listing Regulations, Gujarat Themi..
MORE
Financials
Rs. in Millions
QTR Mar 24 ANNUAL 24
Net Profit158.86591.64
Gross Profit 209.49 793.35
Operating Profit 219.49831
Net Sales 420.111698.22
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26643.70 (0.58%)
M.Cap (Rs. in Cr)56616.00
Pfizer (BSE)
 4473.85 (1.59%)
M.Cap (Rs. in Cr)20466.85
Glaxosmithkline Phar (BSE)
 2355.75 (2.80%)
M.Cap (Rs. in Cr)39907.83
Concord Biotech (BSE)
 1494.85 (4.43%)
M.Cap (Rs. in Cr)15638.55
Zydus Lifesciences (BSE)
 1104.45 (5.00%)
M.Cap (Rs. in Cr)111133.51
MORE
Shareholding Pattern
PROMOTERS 70.86%
NON-INSTITUTION 27.26%
MUTUAL FUNDS/UTI 0.8%
FI/BANKS/INSURANCE 0.01%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
Motilal Oswal S&P B...0.07
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal

Notices/Communique Links

BSE | NSE | MCX | CDSL
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.